ArticleFrontiers in cardiovascular medicine2026
Graft to vein fistula with partial thrombosis: a case report.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemodialysis (HD) remains the cornerstone therapy for end-stage renal disease (ESRD), with arteriovenous fistulas (AVFs) generally favored over arteriovenous grafts (AVGs). Nonetheless, AVGs serve as a critical alternative for patients in whom AVF creation is not feasible. AVGs, however, carry risks such as infection, thrombosis, aneurysm formation, steal syndrome, and graft-to-vein fistulas (GVFs). We report the case of a 62-year-old patient with ESRD who developed partial thrombosis secondary to an inadvertent GVF during AVG cannulation. Remarkably, the GVF was preserved as a secondary HD access and remained functional for more than a year without major complications. This case highlights the potential role of GVFs as a viable option in HD access management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.